secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001140361-25-009939
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences files $300M shelf registration and enters ATM sales agreement with Leerink Partners
--------------------------------------------------------------------------------

- Filed Form S-3 to register up to $300M of common stock, preferred, debt, warrants, and units.
- Entered into ATM agreement with Leerink Partners for at-the-market sales of common stock.
- Pays Leerink 3.0% commission on gross proceeds; no minimum sales obligation.
- Sales may occur on Nasdaq or other trading markets; Company can suspend or terminate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000114036125009939/0001140361-25-009939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000114036125009939/ny20045827x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-009939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer